FIN.DE TUBIZE ACT.NOUV.
FTDStockF
€238.20 ▲ +4.20%
Jun 12, 2026
F
FIN.DE TUBIZE ACT.NOUV.
€238.20 ▲ +4.20%
Jun 12, 2026
FTDStockF

About the company

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.

Arberion
Loading market data